Portfolio Companies 2026 for The Column Group: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
The Column Group accounts for 30 tracked companies with verified cap-table data, 30 of which disclose round sizes totalling $5.2B. The median disclosed raise is $137M, and the largest is ORIC Pharmaceuticals at $900M, ahead of Kallyope ($487M) and Hexagon Bio ($323M).
The names that recur most often on these portfolio cap tables are The Column Group (30 companies), Euclidean Capital (6 companies), Lux Capital (5 companies), Atlas Venture (5 companies), Foresite Capital (5 companies), Vida Ventures (4 companies). By latest disclosed round, the market skews Series A (16), Series C (5), Series B (3), Grant (2).
Companies tracked: 30
Disclosed funding total: $5.2B across 30 companies
Median disclosed raise: $137M
Largest raise: ORIC Pharmaceuticals — $900M
Stage mix: Series A 16 · Series C 5 · Series B 3 · Grant 2
